Longitudinal evaluation of cancer-associated biomarkers before and after weight loss in RENEW study participants: implications for cancer risk reduction.

Longitudinal evaluation of cancer-associated biomarkers before and after weight loss in RENEW study participants: implications for cancer risk reduction.

Item
http://www.wikidata.org/entity/Q35294515
An exploratory investigation of links between changes in adipokines and quality of life in individuals undergoing weight loss interventions: possible implications for cancer research.Longterm management of Polycystic Ovarian Syndrome (PCOS)A comparison of open surgery, robotic-assisted surgery and conventional laparoscopic surgery in the treatment of morbidly obese endometrial cancer patients.Recommendations for high-priority research on cancer-related fatigue in children and adults.Obesity and Endometrial Cancer.Assessment of hot flushes and vaginal dryness among obese women undergoing bariatric surgery.Obesity: Risk factors, complications, and strategies for sustainable long-term weight management.Differential Impact of Weight Loss on Nonalcoholic Fatty Liver Resolution in a North American Cohort with Obesity.No causal impact of serum vascular endothelial growth factor level on temporal changes in body mass index in Japanese male workers: a five-year longitudinal study.
P2860

Longitudinal evaluation of cancer-associated biomarkers before and after weight loss in RENEW study participants: implications for cancer risk reduction.

Item
http://www.wikidata.org/entity/Q35294515
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Longitudinal evaluation of can ...... ons for cancer risk reduction.
@ast
Longitudinal evaluation of can ...... ons for cancer risk reduction.
@en
type
label
Longitudinal evaluation of can ...... ons for cancer risk reduction.
@ast
Longitudinal evaluation of can ...... ons for cancer risk reduction.
@en
prefLabel
Longitudinal evaluation of can ...... ons for cancer risk reduction.
@ast
Longitudinal evaluation of can ...... ons for cancer risk reduction.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Longitudinal evaluation of can ...... ons for cancer risk reduction.
@en
P2093
P2860
P304
P31
P356
10.1016/J.YGYNO.2011.12.439
P407
P433
P478
P50
P577
P5875
P698
P921
P932